Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression
- PMID: 28681696
- DOI: 10.1177/1010428317716249
Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression
Abstract
Aberrant changes of N-glycan modifications on proteins have been linked to various diseases including different cancers, suggesting possible avenue for exploring their etiologies based on N-glycomic analysis. Changes in N-glycan patterns during epithelial ovarian cancer development have so far been investigated mainly using serum, plasma, ascites, and cell lines. However, changes in patterns of N-glycans in tumor tissues during epithelial ovarian cancer progression have remained largely undefined. To investigate whether changes in N-glycan patterns correlate with oncogenesis and progression of epithelial ovarian cancer, we profiled N-glycans from formalin-fixed paraffin-embedded tissue slides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and quantitatively compared among different pathological grades of epithelial ovarian cancer and healthy controls. Our results show that among the 80 compositions of N-glycan detected, expression levels of high-mannose type were higher in epithelial ovarian cancer samples than that observed in healthy controls, accompanied by reduced levels of hybrid-type glycans. By applying receiver operating characteristic analysis, we show that a combined panel composed of four high-mannose and three fucosylated neutral complex N-glycans allows for good discrimination of epithelial ovarian cancer from healthy controls. Furthermore, using a statistical analysis of variance assay, we found that different N-glycan patterns, including 2 high-mannose-type, 2 fucosylated and sialylated complex structures, and 10 fucosylated neutral complex N-glycans, exhibited specific changes in N-glycan abundance across epithelial ovarian cancer grades. Together, our results provide strong evidence that N-glycomic changes are a strong indicator for epithelial ovarian cancer pathological grades and should provide avenues to identify novel biomarkers for epithelial ovarian cancer diagnosis and monitoring.
Keywords: N-glycans; epithelial ovarian cancer; formalin-fixed paraffin-embedded tissue section; matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; pathological grades.
Similar articles
-
N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.Mol Cell Proteomics. 2016 Sep;15(9):3003-16. doi: 10.1074/mcp.M116.059816. Epub 2016 Jul 13. Mol Cell Proteomics. 2016. PMID: 27412689 Free PMC article.
-
MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.Proteomics. 2019 Nov;19(21-22):e1800482. doi: 10.1002/pmic.201800482. Epub 2019 Aug 16. Proteomics. 2019. PMID: 31364262
-
N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.J Clin Endocrinol Metab. 2017 Nov 1;102(11):3990-4000. doi: 10.1210/jc.2017-00401. J Clin Endocrinol Metab. 2017. PMID: 28938401 Free PMC article.
-
MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.Adv Cancer Res. 2017;134:85-116. doi: 10.1016/bs.acr.2016.11.009. Epub 2016 Dec 20. Adv Cancer Res. 2017. PMID: 28110657 Free PMC article. Review.
-
MALDI Mass Spectrometry Imaging of N-Linked Glycans in Tissues.Adv Exp Med Biol. 2018;1104:59-76. doi: 10.1007/978-981-13-2158-0_4. Adv Exp Med Biol. 2018. PMID: 30484244 Review.
Cited by
-
Impact of glycoengineering and antidrug antibodies on the anticancer activity of a plant-made lectin-Fc fusion protein.Plant Biotechnol J. 2022 Nov;20(11):2217-2230. doi: 10.1111/pbi.13902. Epub 2022 Aug 19. Plant Biotechnol J. 2022. PMID: 35900183 Free PMC article.
-
The mannose receptor ligands and the macrophage glycome.Curr Opin Struct Biol. 2022 Aug;75:102394. doi: 10.1016/j.sbi.2022.102394. Epub 2022 May 23. Curr Opin Struct Biol. 2022. PMID: 35617912 Free PMC article. Review.
-
Antitumor activity of a lectibody targeting cancer-associated high-mannose glycans.Mol Ther. 2022 Apr 6;30(4):1523-1535. doi: 10.1016/j.ymthe.2022.01.030. Epub 2022 Jan 22. Mol Ther. 2022. PMID: 35077861 Free PMC article.
-
Applications and continued evolution of glycan imaging mass spectrometry.Mass Spectrom Rev. 2023 Mar;42(2):674-705. doi: 10.1002/mas.21725. Epub 2021 Aug 15. Mass Spectrom Rev. 2023. PMID: 34392557 Free PMC article. Review.
-
Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects.Semin Immunopathol. 2024 Oct 21;46(6):16. doi: 10.1007/s00281-024-01025-6. Semin Immunopathol. 2024. PMID: 39432076 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical